|
UBE3B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.355000E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.579200E-03 |
| Normal-vs-Stage2 |
4.417200E-01 |
| Normal-vs-Stage3 |
6.38099999999975E-05 |
| Normal-vs-Stage4 |
6.960000E-04 |
| Stage1-vs-Stage2 |
5.309700E-02 |
| Stage1-vs-Stage3 |
1.973630E-01 |
| Stage1-vs-Stage4 |
4.574600E-01 |
| Stage2-vs-Stage3 |
8.761800E-03 |
| Stage2-vs-Stage4 |
4.308300E-02 |
| Stage3-vs-Stage4 |
7.326400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.223080E-03 |
| Normal-vs-AfricanAmerican |
1.323560E-01 |
| Normal-vs-Asian |
8.400300E-03 |
| Caucasian-vs-AfricanAmerican |
4.237000E-01 |
| Caucasian-vs-Asian |
6.275400E-01 |
| AfricanAmerican-vs-Asian |
5.715000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.003300E-04 |
| Normal-vs-Female |
1.400610E-03 |
| Male-vs-Female |
7.265800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.618540E-03 |
| Normal-vs-Age(41-60Yrs) |
1.136410E-03 |
| Normal-vs-Age(61-80Yrs) |
1.658910E-03 |
| Normal-vs-Age(81-100Yrs) |
1.718140E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.807200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.818000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.963600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.072000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.078800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.615400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.905900E-02 |
| Classical-VS-Follicular |
4.176000E-01 |
| Classical-VS-Other |
1.867620E-01 |
| Classical-VS-Normal |
1.298460E-03 |
| Tall-VS-Follicular |
1.284380E-02 |
| Tall-VS-Other |
7.579000E-01 |
| Tall-VS-Normal |
5.62349999999601E-05 |
| Follicular-VS-Other |
2.376600E-01 |
| Follicular-VS-Normal |
7.944300E-02 |
| Other-VS-Normal |
1.107820E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.956390E-03 |
| Normal-vs-N1 |
8.17260000000042E-05 |
| N0-vs-N1 |
1.325170E-01 |
|
|
